Aging, immunity and cancer

Current Opinion in Immunology

Volumn 16, Issue 2, 2004, Pages 151-156

  Hakim, Frances T ^a   Flomerfelt, Francis A ^a   Boyiadzis, Michael ^a   Gress, Ronald E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

FDC; Follicular dendritic cell; IFN; IL; Interferon; Interleukin; Leukemia inhibitory factor; LIF; M CSF; Macrophage colony stimulating factor; Natural killer; NK; Oncostatin M; OSM; SCF; Stem cell factor; T cell receptor; TCR; TEC; Thymic epithelial cell; TNF

Indexed keywords

AGING; B LYMPHOCYTE; CANCER SUSCEPTIBILITY; CANCER THERAPY; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CELL RENEWAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; EFFECTOR CELL; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNITY; IMMUNOSURVEILLANCE; MEMORY CELL; METASTASIS; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; THYMUS FUNCTION;

AGED; AGING; ANIMALS; B-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOLOGIC MEMORY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASMS; T-LYMPHOCYTES;

EID: 1542321222     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.01.009     Document Type: Review

References (58)

1. Linton P., Thoman M.L. T cell senescence. Front Biosci. 6:2001;D248-D261.
2. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv Immunol. 80:2002;243-284.
3. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S.et al. T cells and aging, January 2002 update. Front Biosci. 7:2002;d1056-d1183 This exhaustive review covers both epidemiological characteristics and cellular mechanisms of T-cell immunosenescence, with particular attention to the growing body of studies under the SENIEUR protocol.
4. Ligthart G.H. The SENIEUR protocol after 16 years: the next step is to study the interaction of ageing and disease. Mech Ageing Dev. 122:2001;136-140.
5. Pawelec G., Ouyang Q., Colonna-Romano G., Candore G., Lio D., Caruso C. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol. 23:2002;330-332.
6. Huppert F.A., Pinto E.M., Morgan K., Brayne C. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev. 124:2003;449-451.
7. Lansdorp P.M., Dragowska W., Thomas T.E., Little M.T., Mayani H. Age-related decline in proliferative potential of purified stem cell candidates. Blood Cells. 20:1994;376-380.
8. Nilsson-Ehle H., Swolin B., Westin J. Bone marrow progenitor cell growth and karyotype changes in healthy 88-year-old subjects. Eur J Haematol. 55:1995;14-18.
9. Ogawa T., Kitagawa M., Hirokawa K. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev. 117:2000;57-68.
10. Anderlini P., Przepiorka D., Lauppe J., Seong D., Giralt S., Champlin R., Korbling M. Collection of peripheral blood stem cells from normal donors 60 years of age or older. Br J Haematol. 97:1997;485-487.
11. Sharp A., Kukulansky T., Globerson A. In vitro analysis of age-related changes in the developmental potential of bone marrow thymocyte progenitors. Eur J Immunol. 20:1990;2541-2546.
12. Stephan R.P., Reilly C.R., Witte P.L. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood. 91:1998;75-88.
13. Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 356:2000;1795-1799.
14. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol. 96:2001;574-578.
15. Borrego F., Alonso M.C., Galiani M.D., Carracedo J., Ramirez R., Ostos B., Pena J., Solana R. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol. 34:1999;253-265.
16. Miyaji C., Watanabe H., Toma H., Akisaka M., Tomiyama K., Sato Y., Abo T. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol. 61:2000;908-916.
17. Bonafe M., Valensin S., Gianni W., Marigliano V., Franceschi C. The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old. Crit Rev Oncol Hematol. 39:2001;227-233.
18. Weksler M.E., Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol. 20:2000;240-249.
19. Fisman D.N., Agrawal D., Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 35:2002;1368-1375.
20. Remarque E.J., Nijhuis E.W., Hinloopen B., Nagelkerken L., van der Velde E.A., Ligthart G.J. Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy aging. Vaccine. 14:1996;127-130.
21. Zheng B., Han S., Takahashi Y., Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev. 160:1997;63-77.
22. Aydar Y., Balogh P., Tew J.G., Szakal A.K. Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation. Eur J Immunol. 32:2002;2817-2826 This paper examines the potential role of follicular dendritic cells (FDCs) in the changes of B-cell function in aging. Young and old FDCs were combined with young B and T cells in an in vitro germinal center, demonstrating a loss in ovalbumin -specific antibody response with older FDCs.
23. Colonna-Romano G., Bulati M., Aquino A., Scialabba G., Candore G., Lio D., Motta M., Malaguarnera M., Caruso C. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev. 124:2003;389-393.
24. Breitbart E., Wang X., Leka L.S., Dallal G.E., Meydani S.N., Stollar B.D. Altered memory B-cell homeostasis in human aging. J Gerontol A Biol Sci Med Sci. 57:2002;B304-B311.
25. Motta M., Ferlito L., Malaguarnera L., Vinci E., Bosco S., Maugeri D., Malaguarnera M. Alterations of the lymphocytic set-up in elderly patients with cancer. Arch Gerontol Geriatr. 36:2003;7-14.
26. Haynes B.F., Markert M.L., Sempowski G.D., Patel D.D., Hale L.P. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol. 18:2000;529-560.
27. De Rosa S.C., Herzenberg L.A., Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 7:2001;245-248.
28. Schwab R., Szabo P., Manavalan J.S., Weksler M.E., Posnett D.N., Pannetier C., Kourilsky P., Even J. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol. 158:1997;4493-4499.
29. Fry T.J., Mackall C.L. Current concepts of thymic aging. Springer Semin Immunopathol. 24:2002;7-22.
30. Ortman C.L., Dittmar K.A., Witte P.L., Le P.T. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol. 14:2002;813-822 This paper analyzes the timecourse of molecular changes characterizing thymic involution, separately analyzing changes in the epithelial and thymocyte populations. The authors demonstrate that thymic involution results from an array of molecular changes in both thymocytes and TECs.
31. Yehuda A.B., Friedman G., Wirtheim E., Abel L., Globerson A. Checkpoints in thymocytopoiesis in aging: expression of the recombination activating genes RAG-1 and RAG-2. Mech Ageing Dev. 102:1998;239-247.
32. Andrew D., Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol. 37:2002;455-463.
33. Andrew D., Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol. 166:2001;1524-1530.
34. Sempowski G.D., Hale L.P., Sundy J.S., Massey J.M., Koup R.A., Douek D.C., Patel D.D., Haynes B.F. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol. 164:2000;2180-2187.
35. Sempowski G.D., Rhein M.E., Scearce R.M., Haynes B.F. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur J Immunol. 32:2002;3066-3070.
36. Forsey R.J., Thompson J.M., Ernerudh J., Hurst T.L., Strindhall J., Johansson B., Nilsson B.O., Wikby A. Plasma cytokine profiles in elderly humans. Mech Ageing Dev. 124:2003;487-493 This paper describes the significant increase in IL-6 levels observed even in the healthy aged.
37. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., Casti A., Franceschi C., Passeri M., Sansoni P. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood. 95:2000;2860-2868.
38. + T cells with aging.
39. + T cells and demonstrate the functional deficits in these cells.
40. ••].
41. Valenzuela H.F., Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol. 105:2002;117-125.
42. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M.et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 101:2003;2711-2720.
43. ••].
44. Hakim F.T., Cepeda R., Kaimei S., Mackall C.L., McAtee N., Zujewski J., Cowan K., Gress R.E. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood. 90:1997;3789-3798.
45. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., Horowitz M.E., Magrath I.T., Shad A.T., Steinberg S.M.et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 332:1995;143-149.
46. Mackall C.L., Gress R.E. Thymic aging and T-cell regeneration. Immunol Rev. 160:1997;91-102.
47. Klein A.K., Patel D.D., Gooding M.E., Sempowski G.D., Chen B.J., Liu C.X., Kurtzberg J., Haynes B.F., Chao N.J. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant. 7:2001;454-466.
48. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., Berenson J.R., Collins R.H., Koup R.A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 355:2000;1875-1881.
49. Mackall C.L., Punt J.A., Morgan P., Farr A.G., Gress R.E. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol. 28:1998;1886-1893.
50. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., Magrath I.T., Wexler L.H., Dimitrov D.S., Gress R.E. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 89:1997;3700-3707.
51. Dumont-Girard F., Roux E., van Lier R.A., Hale G., Helg C., Chapuis B., Starobinski M., Roosnek E. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood. 92:1998;4464-4471.
52. -/- mice spontaneously develop cancers at high frequency in the second year of life.
53. Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 192:2000;755-760.
54. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
55. Stanta G., Campagner L., Cavallieri F., Giarelli L. Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med. 13:1997;55-68.
56. Ershler W.B., Longo D.L. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst. 89:1997;1489-1497.
57. French R.A., Broussard S.R., Meirer W.A., Minshall C., Arkins S., Zachary J.F., Dantzer R., Kelley K.W. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology. 143:2002;690-699.
58. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 99:2002;4592-4600.